ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3125

White Matter Magnetization Transfer Ratio Histogram Peak Height Helps Identifying Inflammatory Neuropsychiatric Systemic Lupus Erythematosus

César Magro Checa1, Ece Ercan2, Bart J Emmer3, Ron Wolterbeek4, Itamar Ronen2, Mark A. Van Buchem2, T. W. J. Huizinga5 and Gerda M. Steup-Beekman5, 1Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Radiology, C.J. Gorter Center for High Field MRI, Department of Radiology, Leiden University Medical Center, Leiden, Netherlands, 3Department of Radiology, Erasmus Medical Center, Rotterdam, Netherlands, 4Department of Medical Statistics and Bioinformatics, Leiden University Medical Center, Leiden, Netherlands, 5Rheumatology, Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Magnetic resonance imaging (MRI), Neuroimaging, neuropsychiatric disorders, phenotypes and systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 10, 2015

Title: Systemic Lupus Erythematosus - Clinical Aspects and Treatment V: Neuropsychiatric Lupus

Session Type: ACR Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: Magnetization
transfer ratio (MTR) can be used to detect microstructural cerebral changes in
normal-appearing brain tissue of neuropsychiatric systemic lupus erythematosus
(NPSLE) patients. Our aim was to assess white matter (WM) and grey matter (GM)
magnetization transfer ratio histogram peak heights (MTR-HPHs) in different
subsets of NPSLE patients with a non-remarkable 3T-brain-MRI and to evaluate
whether these values could highlight different clinically suspected underlying
pathogenic processes, recognize the clinical NPSLE status or be associated with
a specific NPSLE syndrome.

Methods: Sixty-four
SLE-patients with neuropsychiatric symptoms were included. The initial NPSLE
diagnosis and suspected pathogenic underlying process were established by
multidisciplinary evaluation. Furthermore, we performed a re-evaluation of the
disease course and confirmation of the diagnosis 6-18 months later.
Thirty-three patients with central nervous system (CNS) NPSLE and 31 SLE
patients with neuropsychiatric complaints non-related to SLE (NP-non-SLE) were
included. Twenty SLE patients without neuropsychiatric complaints and 36
healthy controls were included for comparison. Differences of mean WM and GM
MTR-HPH values between different NPSLE subgroups (inflammatory or ischemic
NPSLE phenotype), the clinical changes after treatment and the relation with
NPSLE syndromes were evaluated.

Results: The mean and
standard deviation of the WM and GM MTR-HPHs are presented in Table 1. Inflammatory
NPSLE patients have significantly lower WM MTR-HPH than healthy controls (P
< 0.001), SLE (P < 0.001) and NP-non-SLE patients (P <
0.05) (Figure 1). Cognitive disorder, mood disorder and psychosis were related
to lower values and cerebrovascular symptoms to higher values of WM MTR-HPH (P
< 0.05). Furthermore, we show how the mean WM MTR-HPHs increased when the
clinical status of the NPSLE patients improved (P < 0.001) (Figure
1).

Conclusion: WM MTR-HPH has
potential to identify inflammatory NPSLE with CNS involvement corroborating the
usefulness of this technique to detect cerebral changes in NPSLE patients and
to assess clinical changes after treatment.

Table 1. Comparison of white matter and grey matter MTR-HPHs in the study groups

Healthy controls (n=36)

SLE

(n = 20)

NP-non-SLE

(n = 31)

Phenotype

Inflammatory NPSLE

(n=22)

Ischemic NPSLE

(n = 11)

WM MTR-HPH µ

43.37 ± 5.11†

42.74 ± 6.22†

38.35 ± 4.64‡

32.22 ± 7.76

39.42 ± 4.21†

GM MTR-HPH µ

10.01 ± 2.51

10.02 ± 1.92‡

9.81 ± 3.68

7.71 ± 3.25

10.25 ± 2.85

CNS: central nervous system; GM: grey matter; MTR-HPH: magnetization transfer ratio histogram peak height; NP-non-SLE:  SLE patients with neuropsychiatric complaints non associated with CNS involvement due to SLE; NPSLE: neuropsychiatric SLE; SLE: systemic lupus erythematosus; WM: white matter.

* Values are the mean ± standard deviation. 

† Indicates significance level at P < 0.001 when compared with inflammatory NPSLE

‡  Indicates significance level at P < 0.05 when compared with inflammatory NPSLE

µ Peak height values were multiplied by 10,000 for readability.


Disclosure: C. Magro Checa, None; E. Ercan, None; B. J. Emmer, None; R. Wolterbeek, None; I. Ronen, None; M. A. Van Buchem, None; T. W. J. Huizinga, None; G. M. Steup-Beekman, None.

To cite this abstract in AMA style:

Magro Checa C, Ercan E, Emmer BJ, Wolterbeek R, Ronen I, Van Buchem MA, Huizinga TWJ, Steup-Beekman GM. White Matter Magnetization Transfer Ratio Histogram Peak Height Helps Identifying Inflammatory Neuropsychiatric Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/white-matter-magnetization-transfer-ratio-histogram-peak-height-helps-identifying-inflammatory-neuropsychiatric-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/white-matter-magnetization-transfer-ratio-histogram-peak-height-helps-identifying-inflammatory-neuropsychiatric-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology